some lady

hot and tragic [she/her]

[some lady @redheadhurrican]

Dark, dim, and full of Slim Jims ™

[no context sitcoms ☮︎ 🍉 @oocsitcoms]

barbie

[🐢🐢🐢John Green🐢🐢🐢 @johngreen]

Do you guys ever think about tuberculosis?

[🌸 sydney 🌸 tvl spoilers @squid7000]

like I need to ask greta gerwig what influential queerplatonic relationship with a repressed homosexual hurt her so bad

[no context sitcoms ☮︎ 🍉 @oocsitcoms]

barbenheimer weekend has just been this

[Ash Dylan @AshDylanLit]

me watching Titanic: what are those musicians DOING

me on Twitter still: oh I get it

[Jenny Nicholson @JennyENicholson]

No spoilers but if you've seen oppenheimer what's a good squishmallow to bring

[Hank Green @hankgreen]

Remember when my brother was like “Hey big company, you know how you’re trying to evergreen your patent for a twenty year old multi-drug resistant TB drug! Well, if you do, me and my internet friends are going to make your life absolutely miserable!” and then two days later they pledged to not enforce the patent??

Good god that was wild.

[John Green @sportswithjohn]

Just saw the Barbie movie. The film does NOT address the tuberculosis crisis.
I REPEAT: The Barbie Movie is NEARLY TWO HOURS LONG, contains THOUSANDS OF WORDS OF DIALOGUE, and never once even MENTIONS tuberculosis.

[some lady @redheadhurrican]

Man I wasn’t very excited about the sports section on Duolingo, but now I’m pumped to learn about all the hockey terms so I can someday read Bear Town in Swedish!

[ellie 🏳️‍🌈 @daysnotlived]

Hey @Neutrogena, I don't appreciate your parent company's @JNJGlobalHealth @JNJNews evergreening of the bedaquiline patent. This action will kill millions of people in the next 4 years. I can make the tiny effort to find new sunscreen in support of #PatientsNotPatents

[Artemis @Oldwornoutjeans]

You're pulling this when you only invested as low as One Sixth! of the development cost for bedaquiline?!? @JNJNews #PatientsNotPatents @johngreen @hankgreen

[🐢🐢🐢John Green🐢🐢🐢 @johngreen]

J & J had a really, really bad PR day today. They can have a really, really good PR day tomorrow, and I promise @JNJNews that I will celebrate that as loudly and as repeatedly as I have criticized the public-facing position up to now.

[Louis @louismyers110]

It's a no brainer
#patientsnotpatents

[Megan 🌷 @MeGood18]

10M diagnosed per year. 1.5M die per year.
660k over 20 years is 33k average per year.
33k of 10M is 0.33% of all cases in one year.

Big numbers doesn't always mean big things, J&J #PatientsNotPatents

[John Green @sportswithjohn]

Let’s all remember that if @JNJGlobalHealth @jnjnews does the right thing, we celebrate that and them with absolutely raucous enthusiasm. Takes guts to actually choose #PatientsNotPatents.

[🐢🐢🐢John Green🐢🐢🐢 @johngreen]

In just 22 hours, 578,000 people have watched this video about Johnson & Johnson's pursuit of secondary patents for bedaquiline and how this will lead to millions being unable to receive curative treatment for tuberculosis. https://t.co/Zy86nQE7lD #PatientsNotPatents @JNJNews

[🐢🐢🐢John Green🐢🐢🐢 @johngreen]

At the comms meeting tomorrow:
"How did our statement go over online?"
"Well, three million people saw it."
"That's great."
"Forty people liked it."
"Is that good?"
"It's actually unprecedentedly bad. But I kind of think that happened because we're, like, wrong? If you let me send a follow-up tweet that reads, 'Johnson & Johnson will not enforce bedaquiline patents in countries with a high burden of tuberculosis,' it will get SO MANY LIKES."

[John Green @sportswithjohn]

Good morning @JNJNews. Today's gonna be a long day, admin, and I'm sorry about that, but we need your bosses to stop pursuing a secondary patent on bedaquiline and keeping six million people from being treated appropriately for multi-drug resistant tuberculosis. Video at noon.

[🐢🐢🐢John Green🐢🐢🐢 @johngreen]

We've got Wonder Woman on our team! Time for @JNJGlobalHealth to announce they're abandoning all secondary patents on bedaquiline so that multidrug-reistant tuberculosis patients can have affordable access to the best available medication.